Maturation Phenotype of Peripheral Blood Monocyte/Macrophage After Stimulation with Lipopolysaccharides in Irritable Bowel Syndrome


Por: Rodriguez-Fandino, Oscar A., Hernandez-Ruiz, Joselin, Lopez-Vidal, Yolanda, Charua-Guindic, Luis, Escobedo, Galileo, Schmulson, Max J.

Publicada: 1 abr 2017
Resumen:
Background/Aims Abnormal immune regulation and increased intestinal permeability augmenting the passage of bacterial molecules that can activate immune cells, such as monocytes/macrophages, have been reported in irritable bowel syndrome (IBS). The aim was to compare the maturation phenotype of monocytes/macrophages (CD14+) from IBS patients and controls in the presence or absence of Escherichia coli lipopolysaccharides (LPS), in vitro. Methods Mononuclear cells were isolated from peripheral blood of 20 Rome II-IBS patients and 19 controls and cultured with or without LPS for 72 hours. The maturation phenotype was examined by flow cytometry as follows: M1-Early (CD11c(+)CD206(-)), M2-Advanced (CD11c(-)CD206(+)CX3CR1(+)); expression of membrane markers was reported as mean fluorescence intensity (MFI). The Mann-Whitney test was used and significance was set at P < 0.05. Results In CD14+ cells, CD11c expression decreased with vs without LPS both in IBS (MFI: 8766.0 +/- 730.2 vs 12 920.0 +/- 949.2, P < 0.001) and controls (8233.0 +/- 613.9 vs 13 750.0 +/- 743.3, P < 0.001). M1-Early cells without LPS, showed lower CD11c expression in IBS than controls (MFI: 11 540.0 +/- 537.5 vs 13 860.0 +/- 893.7, P = 0.040), while both groups showed less CD11c in response to LPS (P < 0.01). Furthermore, the percentage of ``Intermediate'' (CD11c(+)CD206(+)CX3CR1(+)) cells without LPS, was higher in IBS than controls (IBS = 9.5 +/- 1.5% vs C = 4.9 +/- 1.4%, P < 0.001). Finally, fractalkine receptor (CX3CR1) expression on M2-Advanced cells was increased when treated with LPS in controls but not in IBS (P < 0.001). Conclusions The initial phase of monocyte/macrophage maturation appears to be more advanced in IBS compared to controls. However, the decreased CX3CR1 in patients with IBS, compared to controls, when stimulated with LPS suggests a state of immune activation in IBS.

Filiaciones:
Rodriguez-Fandino, Oscar A.:
 Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Unidad Invest Med Expt,Lab Higado Pancreas & Moti, Dr Balmis 148, Mexico City 06726, DF, Mexico

 Fdn Univ Unitrop, Direcc Invest, Yopal, Colombia

Hernandez-Ruiz, Joselin:
 Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Unidad Invest Med Expt,Lab Higado Pancreas & Moti, Dr Balmis 148, Mexico City 06726, DF, Mexico

Lopez-Vidal, Yolanda:
 Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Programa Immunol Mol Microbiana, Mexico City, DF, Mexico

Charua-Guindic, Luis:
 Hosp Gen Mexico City, Unidad Coloproctol, Mexico City, DF, Mexico

Escobedo, Galileo:
 Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Unidad Invest Med Expt,Lab Higado Pancreas & Moti, Dr Balmis 148, Mexico City 06726, DF, Mexico

Schmulson, Max J.:
 Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Unidad Invest Med Expt,Lab Higado Pancreas & Moti, Dr Balmis 148, Mexico City 06726, DF, Mexico
ISSN: 20930879
Editorial
Journal of Neurogastroenterology and Motility, RM 305, LOTTE GOLD ROSE VILL II, 31 SEOLLEUNG-RO 86-GIL, GANGNAM-GU, SEOUL 135-839, SOUTH KOREA
Tipo de documento: Article
Volumen: 23 Número: 2
Páginas: 281-288
WOS Id: 000399039900016
ID de PubMed: 28044051

MÉTRICAS